Failure of Medical Therapy in Pulmonary Arterial Hypertension Is There an Alternative Diagnosis?

被引:21
作者
Harch, Susan [1 ]
Whitford, Helen [2 ]
McLean, Catriona [1 ]
机构
[1] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3181, Australia
[2] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic 3181, Australia
关键词
VENOOCCLUSIVE DISEASE; PROSTACYCLIN; BOSENTAN; EDEMA;
D O I
10.1378/chest.08-2006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Despite the development of targeted therapies for pulmonary arterial hypertension (PAH), some patients fail to respond to medical therapy. There are a number of types of PAH, one of which is pulmonary venoocclusive disease (PVOD). Unlike other PAH types, the hallmark pathology of PVOD is fibrous occlusion of the small venules, potentially with arterial involvement. It was hypothesized that a lack of response to medical therapy in clinically diagnosed PAH can be explained by misdiagnosed PVOD. Methods: This study reviewed cases of 14 patients with clinically diagnosed PAH who had failed to respond to medical therapy and had lung tissue available from autopsy or explant. Control samples (n = 6) were obtained from lungs explanted for other causes, and at previous transthoracic echocardiogram excluded pulmonary hypertension. Comprehensive vessel morphometry was performed, and the clinical data reviewed. Results: Vessel analysis confirmed 86% of case patients had PVOD and 14% had arterial-only PAH (artPAH). In the PVOD case patients, significant pathology was present in all vessel types with similar obstructive, intimal fibrosis in the venules (p < 0.0001) and arterioles (p < 0.0001). This was considerably different from the intimal concentric laminar smooth muscle proliferation in the artPAH cases. There were no significant differences in clinical presentation between PVOD and artPAH case patients. Pulmonary edema was not observed in the PVOD cases. Conclusions: PVOD is an underdiagnosed and commonly, misdiagnosed cause of pulmonary hypertension, which may present with a failure to respond to medical therapy. Further studies on PVOD may help confirm whether a change in its classification as a type of PAH is necessary. (CHEST 2009; 135:1462-1469)
引用
收藏
页码:1462 / 1469
页数:8
相关论文
共 18 条
[11]   Pathologic assessment of vasculopathies in pulmonary hypertension [J].
Pietra, GG ;
Capron, F ;
Stewart, S ;
Leone, O ;
Humbert, M ;
Robbins, IM ;
Reid, LM ;
Tuder, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :25S-32S
[12]   HISTOPATHOLOGY OF PRIMARY PULMONARY-HYPERTENSION - A QUALITATIVE AND QUANTITATIVE STUDY OF PULMONARY BLOOD-VESSELS FROM 58 PATIENTS IN THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE, PRIMARY PULMONARY-HYPERTENSION REGISTRY [J].
PIETRA, GG ;
EDWARDS, WD ;
KAY, JM ;
RICH, S ;
KERNIS, J ;
SCHLOO, B ;
AYRES, SM ;
BERGOFSKY, EH ;
BRUNDAGE, BH ;
DETRE, KM ;
FISHMAN, AP ;
GOLDRING, RM ;
GROVES, BM ;
LEVY, PS ;
REID, LM ;
VREIM, CE ;
WILLIAMS, GW .
CIRCULATION, 1989, 80 (05) :1198-1206
[13]  
RUBIN L, 2006, CHEST S, V126, pS7
[14]   Bosentan therapy for pulmonary arterial hypertension [J].
Rubin, LJ ;
Badesch, DB ;
Barst, RJ ;
Galiè, N ;
Black, CM ;
Keogh, A ;
Pulido, T ;
Frost, A ;
Roux, S ;
Leconte, I ;
Landzberg, M ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :896-903
[15]   Clinical classification of pulmonary hypertension [J].
Simonneau, G ;
Galiè, N ;
Rubin, LJ ;
Langleben, D ;
Seeger, W ;
Domenighetti, G ;
Gibbs, S ;
Lebrec, D ;
Speich, R ;
Beghetti, M ;
Rich, S ;
Fishman, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :5S-12S
[16]   PRIMARY PULMONARY HYPERTENSION - A PATHOLOGIC STUDY OF LUNG VESSELS IN 156 CLINICALLY DIAGNOSED CASES [J].
WAGENVOORT, CA ;
WAGENVOORT, N .
CIRCULATION, 1970, 42 (06) :1163-+
[17]   PULMONARY VENO-OCCLUSIVE DISEASE - INVOLVEMENT OF PULMONARY-ARTERIES AND REVIEW OF THE LITERATURE [J].
WAGENVOORT, CA ;
WAGENVOORT, N ;
TAKAHASHI, T .
HUMAN PATHOLOGY, 1985, 16 (10) :1033-1041
[18]   LUNG-BIOPSY SPECIMENS IN THE EVALUATION OF PULMONARY VASCULAR-DISEASE [J].
WAGENVOORT, CA .
CHEST, 1980, 77 (05) :614-625